US5093232A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Nucleic acid probes
Assignee: Bayer Corp
•
Filing: 1986-12-23
•
Granted: 1992-03-03
•
Expires: 2006-12-23
Abstract
Abstract Modified nucleotides are provided which have the structure <IMAGE> wherein R1 is a reactive group derivatizable with a detectable label, R2 is an optional linking moiety including an amide, thioether or disulfide linkage or a combination thereof, R3 is hydrogen, methyl, bromine, fluorine or iodine, R4 is hydrogen, an acid-sensitive, base-stable blocking group of an acyl capping group, R5 is hydrogen or a phosphorus derivative, R6 is H, OH, or OR where R is a protecting group and x is an integer in the range of 1 and 8 inclusive. Methods of synthesizing the derivatizable nucleotide are disclosed, as are labeled polynucleotide probes prepared therefrom.
Inventors
- 👤 Michael S. Urdea
- 👤 Thomas Horn
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-29 17:38
CPC Classifications
C; C07; C07H; C07H19/00; C07H19/02; C07H19/04; C07H19/06; C07H19/10; C07H21/00; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816; C12Q1/682; C12Q1/70; C12Q1/701; C12Q1/706; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55
Claims Analysis
Total Claims: 15
Claim 1
Independent Claim
134 words
A modified nucleotide having the structure ##STR22## wherein: R 1 is a protected or unprotected --NH 2 , --COOH or --SH group; R 2 is a covalent bond or an amide linking moiety with the priviso that the amide linkage is oriented --NH--C(═O)--; R 3 is hydrogen, methyl, bromine, fluorine or iodine; R 4 is selected from the group consisting of hydrogen, acid-sensitive, base-stable blocking groups and acyl capping groups; R 5 is a phosphorus derivative selected from the group consisting of PO 3 H 2 , phosphotriesters, phosphodiesters, phosphites, phosphoramidites, H-phosphonates and phosphorothioates; R 6 is H, OH, or OR where R is an acid-sensitive, base-stable protecting group; and x is an integer in the range of 1 and 8 inclusive, wherein the nucleotide may bound through R 5 to a solid support.
Claim 2
Dependent Claim
134 words
A modified nucleotide having the structure ##STR22## wherein: R 1 is a protected or unprotected --NH 2 , --COOH or --SH group; R 2 is a covalent bond or an amide linking moiety with the priviso that the amide linkage is oriented --NH--C(═O)--; R 3 is hydrogen, methyl, bromine, fluorine or iodine; R 4 is selected from the group consisting of hydrogen, acid-sensitive, base-stable blocking groups and acyl capping groups; R 5 is a phosphorus derivative selected from the group consisting of PO 3 H 2 , phosphotriesters, phosphodiesters, phosphites, phosphoramidites, H-phosphonates and phosphorothioates; R 6 is H, OH, or OR where R is an acid-sensitive, base-stable protecting group; and x is an integer in the range of 1 and 8 inclusive, wherein the nucleotide may bound through R 5 to a solid support.
Claim 3
Dependent Claim
27 words
The modified nucleotide of claim 1 which has the structure ##STR23## wherein the subscripts "x" are each independently integers in the range of 1 and 8 inclusive.
Claim 4
Dependent Claim
17 words
The modified nucleotide of claim 2, wherein R 1 is a protected or unprotected --NH 2 group.
Claim 5
Dependent Claim
14 words
The modified nucleotide of claim 3, wherein R 4 and R 6 are hydrogen.
Claim 6
Dependent Claim
11 words
The modified nucleotide of claim 1 given by the structure ##STR24##
Claim 7
Dependent Claim
17 words
The modified nucleotide of claim 1 covalently bound to a detectable label through said R 1 moiety.
Claim 8
Dependent Claim
13 words
The modified nucleotide of claim 6, wherein said detectable label comprises horseradish peroxidase.
Claim 9
Dependent Claim
12 words
The modified nucleotide of claim 6, wherein said detectable label comprises biotin.
Claim 10
Dependent Claim
16 words
The modified nucleotide of claim 8 bound via biotin-avidin interaction to a support coated with avidin.
Claim 11
Dependent Claim
14 words
The modified nucleotide of claim 6, wherein said detectable label comprises a fluorescent moiety.
Claim 12
Dependent Claim
12 words
The modified nucleotide of claim 10, wherein said fluorescent moiety comprises fluorescein.
Claim 13
Dependent Claim
17 words
The modified nucleotide of claim 1, wherein R 1 is a protected or unprotected --NH 2 group.
Claim 14
Dependent Claim
14 words
The modified nucleotide of claim 12, wherein R 4 and R 6 are hydrogen.
Claim 15
Dependent Claim
114 words
A method of detecting a polynucleotide analyte in a sample, comprising the sequential steps of: rendering any double-stranded polynucleotides in said sample single-stranded; contacting said sample with a polynucleotide probe containing a plurality of modified nucleotides according to claim 1 incorporated at predetermined, spaced apart positions, and having a nucleotide sequence complementary to a predetermined sequence in said analyte such that said probe will hybridize to said analyte, wherein said contacting is for a time sufficient for labeled nucleic acid complexes to form between said probe and said analyte; isolating any such labeled nucleic acid complexes; and detecting the presence of said labeled nucleic acid complexes to indicate the presence of said polynucleotide analyte.
References Cited (Backward Citations)
EP0063879A2
Cited
WO1984003285A1
Cited
US4948882A
Cited
EP0123300A2
Cited
US4626501A
Cited
WO1986000292A1
Cited
US4563417A
Cited
US4828979A
Cited
US4780405A
Cited
US4904582A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-03-03 | 1995-09-02 | 1996-03-03 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-03-03 | 1999-09-02 | 2000-03-03 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-03-03 | 2003-09-02 | 2004-03-03 | $7700.00 | Window Closed / Lapsed |